...
首页> 外文期刊>The Chinese-German Journal of Clinical Oncology >mRNA Expression of the Cancer-testis Antigens SSX1 and SSX4 in Human Hepatocellular Carcinomas
【24h】

mRNA Expression of the Cancer-testis Antigens SSX1 and SSX4 in Human Hepatocellular Carcinomas

机译:肝细胞癌中睾丸抗原SSX1和SSX4的mRNA表达

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To detect the mRNA expression of the cancer-testis antigens (CT) SSX1 and SSX4 gene in human hepatocellular carcinomas (HCCs) and to investigate the specificity of their expression in HCCs. Methods: The mRNA expression of SSX1 and SSX4 in HCC tissues and the corresponding nearby liver tissues in 35 cases was detected by using RT-PCR; Six positive RT-PCR products were randomly selected and sequenced. Results: In all 35 HCC tissues, SSX1 in 27 cases (81%) and SSX4 in 23 cases (73%) were detected, and their expression was negative in the liver tissues nearby HCC and the non-tumor liver tissues (12 cirrhotic tissues and 15 normal tissues). In all 6 cases selected randomly, the results of DNA sequencing were identical with the cDNA sequence of SSX1 and SSX4 genes. The SSX1. SSX4 mRNA expression was not significantly correlated with age, sex, the tumor size, the level of tumor differentiation, the serum AFP level and the infection rate of HBV and HCV respectively (P>0.05). Conclusion: The SSX1, SSX4 mRNA expression was greatly specific in HCCs, which would not only provide the ideal target molecular sites for HCC tumor vaccines, but also establish the potential value of the polyvalent tumor-antigen vaccines for HCC therapy and its theory bases.
机译:目的:检测人肝细胞癌(HCCs)的睾丸抗原(CT)SSX1和SSX4基因的mRNA表达,并探讨其在肝癌中的特异性。方法:采用RT-PCR技术检测35例肝癌组织及附近相应肝组织中SSX1和SSX4的mRNA表达。随机选择六种阳性RT-PCR产物并进行测序。结果:在所有35例HCC组织中,检测到27例SSX1(81%)和23例SSX4(73%),在HCC附近的肝组织和非肿瘤肝组织(12例肝硬化组织)中均检测到阴性。和15个正常组织)。在随机选择的所有6个病例中,DNA测序的结果与SSX1和SSX4基因的cDNA序列相同。 SSX1。 SSX4 mRNA的表达与年龄,性别,肿瘤大小,分化程度,血清AFP水平以及HBV和HCV感染率均无显着相关性(P> 0.05)。结论:SSX1,SSX4 mRNA在肝癌组织中的表达具有很高的特异性,不仅为肝癌肿瘤疫苗提供了理想的靶分子位点,而且为肝癌多价抗原疫苗的建立及其潜在的理论基础奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号